Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study.

Autor: Flanagan KC; Cofactor Genomics Inc, Saint Louis, Missouri, USA kevin_flanagan@cofactorgenomics.com., Earls J; Cofactor Genomics Inc, Saint Louis, Missouri, USA., Hiken J; Cofactor Genomics Inc, Saint Louis, Missouri, USA., Wellinghoff RL; Cofactor Genomics Inc, Saint Louis, Missouri, USA., Ponder MM; Cofactor Genomics Inc, Saint Louis, Missouri, USA., McLeod HL; Utah Tech University, St George, Utah, USA., Westra WH; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Vavinskaya V; Division of Hematology and Oncology, UCSD Moores Cancer Center, La Jolla, California, USA., Sutton L; UCSD Moores Cancer Center, La Jolla, California, USA., Deichaite I; Radiation Medicine and Applied Sciences, UCSD Moores Cancer Center, La Jolla, California, USA., Macdonald OK; Cancer Care Northwest, Spokane Valley, Washington, USA., Welaya K; CoxHealth Medical Oncology, Springfield, Missouri, UK., Wade J 3rd; Decatur Memorial Hospital, Decatur, Illinois, USA., Azzi G; Holy Cross Hospital Medical Group, Fort Lauderdale, Florida, USA., Pippas AW; John B Amos Cancer Center, Columbus Regional Research Institute, Centricity Research, Columbus, Georgia, USA., Slim J; Multicare Institute for Research and Innovation, Tacoma, Washington, USA., Bank B; Northwest Oncology & Hematology, Elk Grove Village, Illinois, USA., Sui X; Providence Regional Cancer System, Lacey, Washington, USA., Kossman SE; Sharp Clinical Oncology Research, San Diego, California, USA., Shenkenberg TD; Valley Cancer Associates, Harlingen, Texas, USA., Alexander WL; William Beaumont Army Medical Center and The Geneva Foundation, Fort Bliss, Texas, USA., Price KA; Mayo Clinic, Rochester, Minnesota, USA., Ley J; Division of Oncology, Department of Medicine, Washington University in St Louis School of Medicine, St Louis, Missouri, USA., Messina DN; Cofactor Genomics Inc, Saint Louis, Missouri, USA., Glasscock JI; Cofactor Genomics Inc, Saint Louis, Missouri, USA., Colevas AD; Stanford University, Stanford, California, USA., Cohen EEW; Division of Hematology and Oncology, University of California San Diego, La Jolla, California, USA., Adkins D; Division of Oncology, Department of Medicine, Washington University in St Louis School of Medicine, St Louis, Missouri, USA., Duncavage EJ; Department of Pathology and Immunology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Nov 03; Vol. 12 (11). Date of Electronic Publication: 2024 Nov 03.